Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome

Journal of Rheumatology

Volumn 33, Issue 9, 2006, Pages 1881-1882

  Sucker, Christoph ^a,b   Wenzel, Folker ^a   Zotz, Rainer B ^a   Hetzel, Gerd R ^a   Scharf, Rüdiger E ^a  

^a Department of Hemostasis and Transfusion Medicine ^*

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Antiphospholipid syndrome; Lupus anticoagulant; Monitoring; Oral anticoagulation

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; PHENPROCOUMON; PREDNISOLONE;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DEEP VEIN THROMBOSIS; HUMAN; IN VITRO STUDY; INTERNATIONAL NORMALIZED RATIO; MALE; MONITORING; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION FACTORS; DIAGNOSTIC ERRORS; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 33748533814     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Morgan M, Downs K, Chesterman CN, Biggs JC. Clinical analysis of 125 patients with the lupus anticoagulant. Aust NZ J Med 1993;23:151-6.
2. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
3. Petri M. Epidemiology of the antiphospholipid syndrome. J Autoimmun 2000;15:145-51.
4. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1,000 patients. Medicine Baltimore 1993;72:113-24.
5. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;346:752-63.
6. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J, Branch DW. Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994;83:372-7.
7. Sanfelippo MJ, Sennet J, McMahon EJ. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant. World Med J 2000;99:62-4.
8. Meroni PL, Moia M, Derksen RH, et al. Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis. Lupus 2003;12:504-7.